Regine Ragette1, Yi Wang, Gerhard Weinreich, Helmut Teschler. 1. Ruhrlandklinik, Department of Respiratory Medicine, Faculty of Medicine, University of Duisburg-Essen, Tüschener Weg 40, Essen, Germany. regine.ragette@uni-due.de
Abstract
BACKGROUND: ApneaLink is a novel single-channel screening device for sleep apnea detection which is based on pressure-transduced measurement of oronasal airflow, summarised as respiratory disturbance index per hour of recording time (RDI(ApneaLink)). We tested ApneaLink's diagnostic performance in a patient population with high prevalence of sleep apnea. METHODS: ApneaLink was applied simultaneously with in-laboratory polysomnography (PSG) (n = 102, 24 female, age 54.7 years) and sequentially with PSG in the unattended home setting (n = 131, 37 female, age 59.1 years). Predictive values were computed for apnea-defining thresholds of apnea-hypopnea index (AHI) >or= 5/h, >or=10/h, >or=15/h. Night-to-night variability (NNV) was assessed over three consecutive nights (n = 55, 10 female, age 48.9 years). RESULTS: RDI(ApneaLink) correlated well with apnea-hypopnea index on PSG (PSG(AHI)) on simultaneous (r = 0.98, bias -0.7) and unattended home application (r = 0.95, bias -0.6). Predictive values were highest at AHI >or= 10/h (in-laboratory: sensitivity 91.1%, specificity 87.5%, LR+ (positive likelihood ratio) 7.4, LR- 0.1; home: sensitivity 80%, specificity 85.5%, LR+5.5, LR- 0.2). NNV was low (V = 0.58 +/- 0.44, range 0-1.69). CONCLUSION: ApneaLink is an accurate screening tool for sleep apnea in a population with high prevalence of the disorder.
BACKGROUND: ApneaLink is a novel single-channel screening device for sleep apnea detection which is based on pressure-transduced measurement of oronasal airflow, summarised as respiratory disturbance index per hour of recording time (RDI(ApneaLink)). We tested ApneaLink's diagnostic performance in a patient population with high prevalence of sleep apnea. METHODS: ApneaLink was applied simultaneously with in-laboratory polysomnography (PSG) (n = 102, 24 female, age 54.7 years) and sequentially with PSG in the unattended home setting (n = 131, 37 female, age 59.1 years). Predictive values were computed for apnea-defining thresholds of apnea-hypopnea index (AHI) >or= 5/h, >or=10/h, >or=15/h. Night-to-night variability (NNV) was assessed over three consecutive nights (n = 55, 10 female, age 48.9 years). RESULTS: RDI(ApneaLink) correlated well with apnea-hypopnea index on PSG (PSG(AHI)) on simultaneous (r = 0.98, bias -0.7) and unattended home application (r = 0.95, bias -0.6). Predictive values were highest at AHI >or= 10/h (in-laboratory: sensitivity 91.1%, specificity 87.5%, LR+ (positive likelihood ratio) 7.4, LR- 0.1; home: sensitivity 80%, specificity 85.5%, LR+5.5, LR- 0.2). NNV was low (V = 0.58 +/- 0.44, range 0-1.69). CONCLUSION: ApneaLink is an accurate screening tool for sleep apnea in a population with high prevalence of the disorder.
Authors: F Portier; A Portmann; P Czernichow; L Vascaut; E Devin; D Benhamou; A Cuvelier; J F Muir Journal: Am J Respir Crit Care Med Date: 2000-09 Impact factor: 21.405
Authors: S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle Journal: Circulation Date: 1998-06-02 Impact factor: 29.690
Authors: Lynda D Lisabeth; Brisa N Sánchez; Ronald D Chervin; Lewis B Morgenstern; Darin B Zahuranec; Susan D Tower; Devin L Brown Journal: Sleep Med Date: 2016-02-12 Impact factor: 3.492
Authors: Devin L Brown; Ashkan Mowla; Mollie McDermott; Lewis B Morgenstern; Garnett Hegeman; Melinda A Smith; Nelda M Garcia; Ronald D Chervin; Lynda D Lisabeth Journal: J Stroke Cerebrovasc Dis Date: 2014-12-10 Impact factor: 2.136